SupportLoginSign Up
Featured FeedJournalsCollectionsKeywords
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Bullous systemic erythematosus. A case report.

J Aboobaker, R Ramsaroop, I Abramowitz, A D Naran
South African Medical Journal 1986 January 5
Bullous disease in patients with systemic lupus erythematosus (SLE) has been previously described but characterization has been difficult. A case of bullous eruption that is an unusual manifestation of SLE rather than a primary vesiculobullous eruption is described. The patient was successfully treated with dapsone.

Full text links

Find Full Text Links for this Article

Trending Papers

Management of Latent Tuberculosis Infection.Steven Kim, Rebecca Thal, Daria SzkwarkoJAMA 2023 January 20
The Difficult Airway Redefined.Matthew B Burgess et al.Prehospital and Disaster Medicine 2022 November 10
Inappropriate Use of Proton Pump Inhibitors Increases Cardiovascular Events in Patients with Coronary Heart Disease.Wen Hu, Yunhao Luo, Xiujuan YangInternational Journal of General Medicine 2022

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Do Not Sell My Personal InformationManage Cookie Preferences

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app